Aluma Endovascular Systems

Advanced Laser Energy Delivery Systems With Proprietary Fiber Technology Integrated Into Catheters

Health Tech & Life Sciences
Active
Seed Founded 2025
Total raised
Last: Seed 2025-10
Stage
Seed
Founded
2025
Headcount
5
HQ
Sector
Health Tech & Life Sciences

About

ALUMA Endovascular Systems develops advanced laser energy delivery systems featuring a unique fiber composition integrated into catheters. This technology is intended to deliver highly localized, high-energy laser pulses directly to targeted areas, overcoming the power limitations of existing solutions. The company’s innovation initially addresses a significant unmet medical need affecting millions of patients with chronic disease in small arteries, a condition with limited treatment options and high morbidity and mortality rates. ALUMA was founded in collaboration with Elbit Systems, leveraging combined expertise in laser science and electro-optics, and Shaare Zedek Scientific Ltd. (Mada’it), the research and innovation branch of Shaare Zedek Medical Center in Jerusalem. This partnership blends technological and clinical expertise to serve as the foundation for ongoing innovation.

Funding history · 2 rounds · — total

2025-10
Seed Undisclosed
2025-09
Undisclosed Undisclosed

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

When was Aluma Endovascular Systems founded?
Aluma Endovascular Systems was founded in August 2025.
What is Aluma Endovascular Systems' primary focus?
Aluma Endovascular Systems develops advanced laser energy delivery systems with proprietary fiber technology integrated into catheters, designed to deliver highly localized, high-energy laser pulses.
What medical need does Aluma Endovascular Systems' technology address?
Aluma Endovascular Systems' technology initially addresses the unmet medical need of chronic disease in small arteries, a condition with limited treatment options.
Which organizations did Aluma Endovascular Systems collaborate with for its founding?
Aluma Endovascular Systems was founded in collaboration with Elbit Systems and Shaare Zedek Scientific Ltd. (Mada’it), the research and innovation branch of Shaare Zedek Medical Center in Jerusalem.
What was the purpose of the collaboration between Aluma Endovascular Systems, Elbit Systems, and Shaare Zedek Scientific Ltd.?
The collaboration aimed to leverage combined expertise in laser science, electro-optics, and clinical knowledge to serve as the foundation for ongoing innovation.
When did Aluma Endovascular Systems receive its first disclosed funding?
Aluma Endovascular Systems received an Undisclosed round of funding in September 2025.
Which investor participated in Aluma Endovascular Systems' funding rounds in 2025?
Peregrine Ventures participated in Aluma Endovascular Systems' Undisclosed round in September 2025 and Seed round in October 2025.
What is the current employee count for Aluma Endovascular Systems?
Aluma Endovascular Systems currently has 5 employees.
Who is a founder of Aluma Endovascular Systems?
Ori Kanner is a founder of Aluma Endovascular Systems.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Business model
B2B